Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 4, 1996, Pages 1339-1346

  Rubins, Jeffrey B ^a   Charboneau, Darlene ^b   Fasching, Claudine ^b   Berry, Anne M ^b   Paton, James C ^b   Alexander, Janet E ^b   Andrew, Peter W ^b   Mitchell, Timothy J ^b   Janoff, Edward N ^b  

^a VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN; PNEUMOLYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HEMOLYSIS; LOBAR PNEUMONIA; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0029986122     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.4.8616564     Document Type: Article

References (20)

1. Kramer, M. R., B. Rudensky, I. Hadas-Halperin, M. Isacsohn, and E. Melzer. 1987. Pneumococcal bacteremia-no change in mortality in 30 years: analysis of 104 cases and review of the literature, Isr. J. Med. Sci. 23:174-180.
2. Jetté, L. P., and F. Lamothe. 1989. Surveillance of invasive Streptococcus pneumoniae infection in Québec, Canada, from 1984 to 1986: sero-type distribution, antimicrobial susceptibility, and clinical characteristics. J. Clin. Microbiol. 27:1-5.
3. Musher, D. M. 1992. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-809.
4. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest. 95:142-150.
5. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton, G. J. Boulnois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172:119-123.
6. Mitchell, T. J., P. W. Andrew, F. K. Saunders, A. N. Smith, and G. J. Boulnois. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute phage protein. Mol. Microbiol. 5:1883-1888.
7. Boulnois, G. J., J. C. Paton, T. J. Mitchell, and P. W. Andrew. 1991. Structure and function of pneumolysin, the multifunctional, thiolactivated toxin of Streptococcus pneumoniae. Mol. Microbiol. 5: 2611-2616.
8. Rubins, J. B., P. G. Duane, D. Charboneau, and E. N. Janoff. 1992. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Immun. 60:1740-1746.
9. Rubins, J. B., P. G. Duane, D. Clawson, D. Charboneau, J. Young, and D. E. Niewoehner. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61:1352-1358.
10. Feldman, C., N. C. Munro, P. K. Jeffery, T. J. Mitchell, P. W. Andrew, G. J. Boulnois, D. Guerreiro, J. A. L. Rohde, H. C. Todd, P. J. Cole, and R. Wilson. 1991. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am. J. Respir. Cell Mol. Biol. 5:416-423.
11. Johnson, M. K., J. A. Hobden, M. Hagenah, R. J. O'Callaghan, J. M. Hill, and S. Chen. 1990. The role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr. Eye Res. 9:1107-1114.
12. Berry, A. M., J. E. Alexander, T. J. Mitchell, P. W. Andrew, D. Hansman, and J. C. Paton. 1995. Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae. Infect. Immun. 63:1969-1974.
13. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.
14. Esposito, A. L., and J. E. Pennington. 1983. Effects of aging on antibacterial mechanisms in experimental pneumonia. Am. Rev. Respir. Dis. 128:662-667.
15. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hygiene 27:493-497.
16. Gray, B. M. 1990. Opsonophagocidal activity in sera from infants and children immunized with Haemophilus influenza type b conjugate vaccine (meningococcal protein conjugate). Pediatrics 85:694-697.
17. Miculek, S., E. L. Anderson, and B. M. Gray. 1991. Opsonophagocidal antibodies to pneumococcus group 6 in infants and children given a new polysaccharide conjugate vaccine (abstract). Clin. Res. 39:842A.
18. Wood, W. B. J. 1941. Studies on the mechanism of recovery in pneumococcal pneumonia, I: the action of type specific antibody upon the pulmonary lesion of experimental pneumonia. J. Exp. Med. 73: 201-222.
19. Bhakdi, S., and J. Tranum-Jensen. 1985. Complement activation and attack on autologous cell membranes induced by streptolysin-O. Infect. Immun. 48:713-719.
20. Winkelstein, J. A. 1984. Complement and the host's defense against the pneumococcus. Crit. Rev. Microbiol. 11:187-208.